TGA strengthens warnings on antibiotic side effects GPs have been asked to use fluoroquinolones ‘judiciously’, as the Administration rolls out more prominent warnings.
ADHD med shortages ‘a merry-go-round you just can’t predict’ The new school year has coincided with another series of shortages, forcing patients and prescribers to rethink their options.
‘A big difference’: Poisons Standard change brings hope Reduced paracetamol pack sizes are now in force, as a new report highlights the number of children hospitalised due to preventable medicine-related issues.
Most GPs discover medication shortages through patients: Poll A new survey highlights the urgency of improving measures to communicate supply chain disruptions, with patients increasingly feeling an impact.
Extent of non-compliant medicinal cannabis clinics revealed New research has highlighted the need for more stringent monitoring and regulation when it comes to advertising practices around the prescribing of medicinal cannabis products.
Quetiapine shortage ‘frankly unacceptable’ Some doses of the antipsychotic medication could be in shortage until July, leaving both patients and GPs ‘alarmed’.
‘Too little, too late’: An investigation into medication shortages How are medication shortages affecting GPs and their patients? Calls are being made to change how they are being managed and communicated.
Ozempic shortage extended The manufacturer has informed the TGA that supply will be limited until 31 December 2025, with GPs labelling it an ‘ongoing disappointment’.
‘Deeply concerns me’: Original prescriber’s alarm over cannabis trends Medicinal cannabis prescription rates are skyrocketing, with sales in the first half of 2024 almost equal to all of 2023 – but it comes amid mounting concern.
Medical devices impacted by 3G shutdown GPs are being urged to speak to their patients and take ‘necessary precautions’ as essential devices and alarms could be affected.